| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-05 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |